Varicella zoster virus the ACIP recommended a second dose of vaccine before school entry to ensure the maintenance of high levels of varicella immunity. In 2006, the United States Food and Drug Administration approved Zostavax for the prevention of shingles. Zostavax is a more concentrated formulation of the Varivax vaccine, designed to elicit an immune response in older adults whose immunity to VZV wanes with advancing age. A systematic review by the Cochrane Library shows that Zostavax reduces the incidence of shingles by almost 50%. Shingrix is a "V. zoster" vaccine developed by GlaxoSmithKline which was approved in the United States by the
National Technical Institute for the Deaf community are preserved in the RIT/NTID Deaf Studies Archive, which is housed on campus in the RIT Archive Collections at The Wallace Center. National Technical Institute for the Deaf The National Technical Institute for the Deaf (NTID) is the first and largest technological college in the world for students who are deaf or hard of hearing. As one of nine colleges within the Rochester Institute of Technology (RIT) in Rochester, New York, NTID provides academic programs, access, ASL in-class interpreters and support services—including on-site audiological, speech-language, and cochlear implant support. As of fall quarter 2012, NTID encompasses just under 10%